Neurolief's Relivion® Secures Regulatory Approval in Japan, Pioneering At-Home Migraine Treatment
07.08.2025 - 18:07:07 | prnewswire.co.uk
View original content:https://www.prnewswire.co.uk/news-releases/neuroliefs-relivion-secures-regulatory-approval-in-japan-pioneering-at-home-migraine-treatment-302029112.html
en | boerse | 67948043 |
